TYRA
TYRA
NASDAQ · Biotechnology

Tyra Biosciences Inc

$36.32
-0.21 (-0.56%)
As of Mar 24, 10:02 PM ET ·
Financial Highlights (FY 2025)
Revenue
572.13M
Net Income
-99,921,707
Gross Margin
52.8%
Profit Margin
-17.5%
Rev Growth
+16.0%
D/E Ratio
0.49
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 52.8% 52.8% 52.8%
Operating Margin -15.0% -16.8% -15.8%
Profit Margin -17.5% -14.1% -16.5%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 572.13M 572.72M 559.98M
Gross Profit 301.88M 302.20M 295.47M
Operating Income -86,003,646 -96,087,906 -88,298,173
Net Income -99,921,707 -80,567,499 -92,627,690
Gross Margin 52.8% 52.8% 52.8%
Operating Margin -15.0% -16.8% -15.8%
Profit Margin -17.5% -14.1% -16.5%
Rev Growth +16.0% -4.7% +5.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 492.39M 558.04M 500.43M
Total Equity 999.86M 1.02B 990.43M
D/E Ratio 0.49 0.55 0.51
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -119,066,634 -104,548,216 -110,415,827
Free Cash Flow -98,412,160 -88,741,836 -111,480,768